
CL
USDColgate-Palmolive Company Common Stock
Цена в режиме реального времени
График цен
Ключевые показатели
Рыночные показатели
Открытие
$75.800
Максимум
$76.585
Минимум
$75.000
Объем
6.40M
Фундаментальные показатели компании
Рыночная капитализация
61.7B
Отрасль
Household & Personal Products
Страна
United States
Статистические данные торговли
Средний объем
5.80M
Биржа
NYQ
Валюта
USD
52-недельный диапазон
Отчет об анализе ИИ
Последнее обновление: 2 нояб. 2025 г.Colgate-Palmolive (CL): Mixed Signals Near Key Support Level
Company Overview
Colgate-Palmolive (CL), a leader in household and personal care products, operates with 34,000 employees across categories like oral hygiene, pet nutrition, and home care. Its current stock price ($76.51) sits near a 52-week low ($74.62), with a market cap of $62.3B and a P/E ratio of 19.96. The company recently cut its annual sales forecast, citing weak consumer demand, after reporting Q3 revenue growth of 1.9%--below analyst expectations.
Price Action Review
Over the past three months:
- Trend: Bearish. Shares dropped 10.8% from $85.78 (Aug 20) to $76.51 (Oct 31).
- Volatility: Low (avg volume: 5.7M shares), though sudden sell-offs occurred in late October (e.g., $79.86 → $77.14 in 3 days).
- Key Levels:
- Support: $76.37 (Bollinger Band lower bound).
- Resistance: $85.43 (Oct 20 high) and $88.84 (analyst price target).
Technical indicators suggest a bullish breakout is possible if prices hold above $74.95 (stop-loss level). The MACD golden cross and surging On-Balance Volume (15.4x average) hint at short-term buying pressure.
News Sentiment Analysis
Recent headlines show conflicting signals:
- Negative: CL lowered its annual sales forecast on Oct 31, citing "rising economic uncertainty" impacting demand for premium-priced products--even in essentials like toothpaste.
- Neutral: Q3 organic sales rose just 0.4%, dragged down by a "non-strategic exit from private-label pet sales."
- Positive: JP Morgan reiterated an "Overweight" rating on Oct 10, though cutting its price target from $95 to $88.
Analyst sentiment remains optimistic
Связанные новости
Barclays Maintains Equal-Weight on Colgate-Palmolive, Lowers Price Target to $80
Barclays analyst Lauren Lieberman maintains Colgate-Palmolive with a Equal-Weight and lowers the price target from $82 to $80.
Procter & Gamble can be sued over Kid's Crest packaging, US judge rules
Procter & Gamble must face a lawsuit alleging that its packaging for Kid's Crest suggests that children can use more of the toothpaste than is safe.
UBS Maintains Buy on Colgate-Palmolive, Lowers Price Target to $90
UBS analyst Peter Grom maintains Colgate-Palmolive with a Buy and lowers the price target from $92 to $90.
Citigroup Maintains Buy on Colgate-Palmolive, Lowers Price Target to $95
Citigroup analyst Filippo Falorni maintains Colgate-Palmolive with a Buy and lowers the price target from $105 to $95.
Morgan Stanley Maintains Overweight on Colgate-Palmolive, Lowers Price Target to $87
Morgan Stanley analyst Dara Mohsenian maintains Colgate-Palmolive with a Overweight and lowers the price target from $96 to $87.
JP Morgan Maintains Overweight on Colgate-Palmolive, Lowers Price Target to $87
JP Morgan analyst Andrea Teixeira maintains Colgate-Palmolive with a Overweight and lowers the price target from $88 to $87.
Evercore ISI Group Maintains Outperform on Colgate-Palmolive, Lowers Price Target to $94
Evercore ISI Group analyst Robert Ottenstein maintains Colgate-Palmolive with a Outperform and lowers the price target from $100 to $94.
Прогноз ИИBeta
Рекомендация ИИ
Обновлено в: 5 нояб. 2025 г., 07:26
64.8% Уверенность
Риск и торговля
Точка входа
$76.25
Взять прибыль
$78.60
Остановить убытки
$74.86
Ключевые факторы
Связанные акции
Оставаться в курсе
Установите ценовой сигнал, получите обновления анализа ИИ и новости рынка в режиме реального времени.